Condition: Atrial Fibrillation · Sponsor: University of South Florida
The goal of this pilot study is to explore the efficacy of chloroquine in terminating persistent AF and assess its potential role as a pharmacological cardioversion agent for the management of AF.
This description comes directly from the study's public registry record.
Thanh Tran, MPH · 813-844-8544 · thanhtran@health.usf.edu
Sami Noujaim, PhD · 813-974-6416 · snoujaim@health.usf.edu
Always discuss trial participation with your own doctor first.
| University of South Florida | Tampa, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02932007